A Peculiar CLL Case with Complex Chromosome 6 Rearrangements and Refinement of All Breakpoints at the Gene Level by Genomic Array: A Case Report
暂无分享,去创建一个
L. Del Vecchio | P. Modena | C. Patriarca | M. Cennamo | A. Squizzato | M. Giagnacovo | D. Ferrario | Emanuela Veniani | G. Petracco | A. Papa | C. Giudici | Davide Sirocchi | Simona Garganigo | Michelarcangelo Partenope
[1] B. Biderman,et al. Ibrutinib in combination with rituximab is highly effective in treatment of chronic lymphocytic leukemia patients with steroid refractory and relapsed autoimmune cytopenias , 2023, Leukemia.
[2] K. Plevova,et al. Chromothripsis in Chronic Lymphocytic Leukemia: A Driving Force of Genome Instability , 2021, Frontiers in Oncology.
[3] L. Laurenti,et al. Autoimmune Hemolytic Anemia in Chronic Lymphocytic Leukemia: A Comprehensive Review , 2021, Cancers.
[4] S. Beà,et al. Balanced and unbalanced translocations in a multicentric series of 2843 patients with chronic lymphocytic leukemia , 2021, Genes, chromosomes & cancer.
[5] W. Barcellini,et al. Autoimmune Complications in Hematologic Neoplasms , 2021, Cancers.
[6] R. Foà,et al. Pre-existing and treatment-emergent autoimmune cytopenias in patients with CLL treated with targeted drugs. , 2021, Blood.
[7] J. Puechberty,et al. Chromoanagenesis, the mechanisms of a genomic chaos. , 2021, Seminars in cell & developmental biology.
[8] W. Barcellini,et al. How I treat warm autoimmune hemolytic anemia. , 2021, Blood.
[9] J. Rupa-Matysek,et al. Autoimmune hemolytic anemia: current knowledge and perspectives , 2020, Immunity & ageing : I & A.
[10] L. Bullinger,et al. Prognostic and predictive impact of genetic markers in patients with CLL treated with obinutuzumab and venetoclax. , 2020, Blood.
[11] E. van den Berg,et al. European recommendations and quality assurance for cytogenomic analysis of haematological neoplasms: reponse to the comments from the Francophone Group of Hematological Cytogenetics (GFCH) , 2020, Leukemia.
[12] M. Boccadoro,et al. Autoimmune Complications in Chronic Lymphocytic Leukemia in the Era of Targeted Drugs , 2020, Cancers.
[13] W. Barcellini,et al. Autoimmune Cytopenias in Chronic Lymphocytic Leukemia: Focus on Molecular Aspects , 2020, Frontiers in Oncology.
[14] U. Jäger,et al. Diagnosis and treatment of autoimmune hemolytic anemia in adults: Recommendations from the First International Consensus Meeting. , 2019, Blood reviews.
[15] M. Hallek. Chronic lymphocytic leukemia: 2020 update on diagnosis, risk stratification and treatment , 2019, American journal of hematology.
[16] S. Berentsen,et al. Defining autoimmune hemolytic anemia: a systematic review of the terminology used for diagnosis and treatment. , 2019, Blood advances.
[17] M. Mabed,et al. The prevalence and prognostic significance of autoimmune cytopenias in a cohort of Egyptian patients with chronic lymphocytic leukemia. , 2019, Hematology/oncology and stem cell therapy.
[18] E. van den Berg,et al. European recommendations and quality assurance for cytogenomic analysis of haematological neoplasms , 2019, Leukemia.
[19] A. Kater,et al. Autoimmune cytopenias in chronic lymphocytic leukemia: a concise review and treatment recommendations , 2018, Expert review of hematology.
[20] S. Berentsen. How I manage patients with cold agglutinin disease , 2018, British journal of haematology.
[21] F. Carrat,et al. Autoimmune manifestations associated with lymphoma: characteristics and outcome in a multicenter retrospective cohort study , 2018, Leukemia & lymphoma.
[22] E. Koritáková,et al. Chromosome 6q deletion correlates with poor prognosis and low relative expression of FOXO3 in chronic lymphocytic leukemia patients , 2017, American journal of hematology.
[23] N. Kay,et al. How I treat autoimmune hemolytic anemia. , 2017, Blood.
[24] C. Demir,et al. Clinical and serological autoimmune complications in chronic lymphocytic leukemia , 2017, Wiener klinische Wochenschrift.
[25] E. Massey,et al. The diagnosis and management of primary autoimmune haemolytic anaemia , 2017, British journal of haematology.
[26] F. Roudot-thoraval,et al. A randomized and double‐blind controlled trial evaluating the safety and efficacy of rituximab for warm auto‐immune hemolytic anemia in adults (the RAIHA study) , 2017, American journal of hematology.
[27] F. Rodeghiero,et al. Evans syndrome secondary to chronic lymphocytic leukaemia: presentation, treatment, and outcome , 2016, Annals of Hematology.
[28] C. Rodrigo,et al. Rituximab in the treatment of autoimmune haemolytic anaemia , 2015, British journal of clinical pharmacology.
[29] T. Fukuda. [Pathogenesis of chronic lymphocytic leukemia]. , 2015, [Rinsho ketsueki] The Japanese journal of clinical hematology.
[30] D. Consonni,et al. Clinical heterogeneity and predictors of outcome in primary autoimmune hemolytic anemia: a GIMEMA study of 308 patients. , 2014, Blood.
[31] Xiao-Jie Yan,et al. Genomic imbalance defines three prognostic groups for risk stratification of patients with chronic lymphocytic leukemia , 2014, Leukemia and Lymphoma.
[32] Cheng-Zhong Zhang,et al. Chromothripsis and beyond: rapid genome evolution from complex chromosomal rearrangements , 2013, Genes & development.
[33] L. Kjeldsen,et al. A phase III randomized trial comparing glucocorticoid monotherapy versus glucocorticoid and rituximab in patients with autoimmune haemolytic anaemia , 2013, British journal of haematology.
[34] Michael Hallek,et al. Chronic lymphocytic leukemia: 2013 update on diagnosis, risk stratification and treatment , 2013, American journal of hematology.
[35] P. Galieni,et al. 6q deletion detected by fluorescence in situ hybridization using bacterial artificial chromosome in chronic lymphocytic leukemia , 2013, European journal of haematology.
[36] M. Shen. Chromoplexy: a new category of complex rearrangements in the cancer genome. , 2013, Cancer cell.
[37] A. Neri,et al. Autoimmune cytopenias in chronic lymphocytic leukemia , 2014, American journal of hematology.
[38] K. Coombes,et al. Genomic variation by whole-genome SNP mapping arrays predicts time-to-event outcome in patients with chronic lymphocytic leukemia: a comparison of CLL and HapMap genotypes. , 2013, The Journal of molecular diagnostics : JMD.
[39] R. Foà,et al. B‐cell receptor configuration and adverse cytogenetics are associated with autoimmune hemolytic anemia in chronic lymphocytic leukemia , 2012, American journal of hematology.
[40] J. Downing,et al. High-resolution genomic profiling of chronic lymphocytic leukemia reveals new recurrent genomic alterations. , 2012, Blood.
[41] M. Jarošová,et al. Array-based karyotyping in chronic lymphocytic leukemia (CLL) detects new unbalanced abnormalities that escape conventional cytogenetics and CLL FISH panel. , 2012, Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia.
[42] F. caligaris-Cappio,et al. A matter of debate in chronic lymphocytic leukemia: is the occurrence of autoimmune disorders an indicator of chronic lymphocytic leukemia therapy? , 2011, Current opinion in oncology.
[43] Hanna Göransson,et al. Array-based genomic screening at diagnosis and during follow-up in chronic lymphocytic leukemia , 2011, Haematologica.
[44] E. Montserrat,et al. Chronic lymphocytic leukemia and autoimmunity: a systematic review , 2011, Haematologica.
[45] E. Montserrat,et al. Autoimmune cytopenia in chronic lymphocytic leukemia: prevalence, clinical associations, and prognostic significance. , 2010, Blood.
[46] Deborah A. Bowen,et al. Autoimmune cytopenia in chronic lymphocytic leukemia/small lymphocytic lymphoma: changes in clinical presentation and prognosis , 2009, Leukemia & lymphoma.
[47] Deborah A. Bowen,et al. The prognostic significance of cytopenia in chronic lymphocytic leukaemia/small lymphocytic lymphoma , 2008, British journal of haematology.
[48] D. Catovsky,et al. The prognostic significance of a positive direct antiglobulin test in chronic lymphocytic leukemia: a beneficial effect of the combination of fludarabine and cyclophosphamide on the incidence of hemolytic anemia. , 2008, Blood.
[49] K. Do,et al. Assessment of chronic lymphocytic leukemia and small lymphocytic lymphoma by absolute lymphocyte counts in 2,126 patients: 20 years of experience at the University of Texas M.D. Anderson Cancer Center. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[50] F. Zaja,et al. Trisomy 8 in chronic lymphocytic leukemia: a report of two cases. , 2007, Cancer Genetics and Cytogenetics.
[51] F. Ferrara,et al. Rituximab therapy for chronic lymphocytic leukemia‐associated autoimmune hemolytic anemia , 2006, American journal of hematology.
[52] R. Foà,et al. Autoimmune hemolytic anemia in chronic lymphocytic leukemia: clinical, therapeutic, and prognostic features. , 2000, Blood.
[53] L. Diehl,et al. Autoimmune disease and chronic lymphocytic leukemia: autoimmune hemolytic anemia, pure red cell aplasia, and autoimmune thrombocytopenia. , 1998, Seminars in oncology.
[54] N. Chiorazzi,et al. mechanisms of disease Chronic Lymphocytic Leukemia , 2010 .
[55] W. Dameshek. Special Article: Chronic Lymphocytic Leukemia—an Accumulative Disease of Immunologically Incompetent Lymphocytes , 1967 .
[56] C. Moreno,et al. Autoimmune Cytopenia in CLL , 2021, Cancer journal.
[57] J. Staaf,et al. Large but not small copy-number alterations correlate to high-risk genomic aberrations and survival in chronic lymphocytic leukemia: a high-resolution genomic screening of newly diagnosed patients , 2010, Leukemia.